STARTUP PROFILE

Syntropic

COUNTRY
Austria
FOUNDED
2023
CATEGORY
Neuromodulation
Using 60 Hz non-invasive light stimulation via the eyes to trigger microglia-mediated neuroplasticity, offering a fast, drug-free option for depression and brain recovery.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Seed
MODALITY
Light/sound
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Psychiatry
TARGET USER
Patients
REGULATORY STAGE
Investigational
Syntropic is pursuing light-based brain stimulation for depression and recovery, with a mechanistic narrative centered on neuroplasticity and microglial response. This is unusual and scientifically interesting, but still firmly preclinical.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Syntropic
No items found.